Skip to content
OpenCapital
Get started

Replimune Group REPL Payments for finance leases

Payments for finance leases at other companies

ImmunityBio, Inc. logo
ImmunityBio, Inc.IBRX
$13K—
Roivant Sciences logo
Roivant SciencesROIV
$0—
Incyte logo
IncyteINCY
$1.18M+8.6%

Other financials

Income statement

See full
Operating income-$71.9M-8.9%
Net income-$70.9M-6.9%
EPS (diluted)-$0.77+2.5%

Balance sheet

See full
Cash & equivalents$124.7M-28.3%
Total debt$79.2M+0.5%
Total equity$210.5M-56.4%
Total assets$333.6M-44.7%

Cash flow

See full
Operating cash flow-$66.0M-30.1%
CapEx$135.0K-92.5%
Free cash flow-$66.1M-25.9%

Valuation

See full
Market cap$930.59M+28.6%
Enterprise value$885.15M+28.3%

Returns & leverage

See full
Return on equity-90.9%+362pp
Debt / equity0.4×+0.2×
Current ratio5.6×-5.8×

Where this comes from

Reported directly by Replimune Group in its filing.

Tagged under the XBRL concept us-gaap:FinanceLeasePrincipalPayments.

The official record: Replimune Group’s 10-Q, filed February 3, 2026, on SEC EDGAR. View the filing →

Ask your AI about Replimune Group's payments for finance leases.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Replimune Group's payments for finance leases?
Replimune Group (REPL) reported payments for finance leases of $195K in Q4 2025.
How has Replimune Group's payments for finance leases changed year-over-year?
Replimune Group's payments for finance leases increased by 22.6% year-over-year, from $159K to $195K.
What is the long-term trend for Replimune Group's payments for finance leases?
Over 3 years (2022 to 2025), Replimune Group's payments for finance leases has grown at a 31.4% compound annual growth rate (CAGR), from $264K to $599K.
What does payments for finance leases mean?
Principal payments on finance lease obligations, reducing the lease liability on the balance sheet.